(Q44177261)

30 November 2017

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194694

28 May 2022

main subject

phase II clinical trial

0 references

author name string

M. H. Cohen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194694

28 May 2022

L. E. Broder

2

0 references

B. E. Fossieck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194694

28 May 2022

D. C. Ihde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194694

28 May 2022

J. D. Minna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A194694

28 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=194694

28 May 2022

publication date

1 May 1977

1 reference

30 November 2017

Cancer Treatment Reports

1 reference

30 November 2017

61

1 reference

30 November 2017

3

1 reference

30 November 2017

489-490

1 reference

30 November 2017

Identifiers

1 reference